Please login to the form below

Not currently logged in
Email:
Password:

Menarini launches urology campaign in Greece

PE information push includes Not Just A Moment website
Menarini Greece premature ejaculation disease awareness

Menarini is supporting a new awareness initiative to educate men about premature ejaculation.

The campaign, which includes the Not Just A Moment website covers topics traditionally seen as taboo in Greece, such as the role of man in today's society, sex education and women's satisfaction during sex, along with a range of information on premature ejaculation.

Premature ejaculation misconceptions and myths are also covered, with possible solutions suggested, and visitors to the website have access to a five question diagnostic test for PE. They can also read experts' answers to key questions about premature ejaculation.

The main goal of the website and the accompanying campaign is to show men and women the importance of the issue of premature ejaculation and how dealing with it will help them improve the quality of their sex lives.

"Premature ejaculation is known to be very difficult to talk about. It is important that the campaign "Not just a moment" opens a window to all those people who are suffering”, said Professor Dimitris Chatzichristou, president of the Institute of Urological Diseases, which develop the website's content.

The campaign should also teach people what premature ejaculation is, how to identify their problem and where to find solutions, added Chatzichristou.

“This is precisely the message of the campaign: There is a solution. It is here for you. We are here and waiting to help you”, he said. 

16th April 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
Pills
Tackling antimicrobial resistance on multiple fronts
An urgent change of direction is needed in how we respond to AMR...

Infographics